Fig 1 Percentage of patients in the combined modified intent-to-treat population with efficacy endpoints accounting specifically for nausea, by treatment.

Slides:



Advertisements
Similar presentations
From: An open day in the metric space
Advertisements

Fig. 1 Flow chart of the COBRA-light trial and its extension study
Fig. 1 Graphical representation
Fig 2 Task related processing times of naïve operators (blue) and experienced operators (orange) given for the four anaesthesia ventilators in the order.
Fig 1 Trends in organ donors in the UK, 2000–10
From: Political Leadership and Power Redistribution
Fig 1 The CONSORT participant flow diagram for primary endpoints.
Fig. 1 Examples of Insulin pump systems
pSS: primary SS; Scl: scleroderma.
Figure 1. Selection of papers.
Fig. 1 Flow chart of study selection
Figure 1. (A) Forest plot of common odds ratios (adjusted for ECOG PS) for best overall response by a priori subgroups in patients with KRAS wild-type.
Fig. 1 Flow of ascertainment of cases with incident childhood IgA vasculitis reported by four sources From: Incidence of IgA vasculitis in children estimated.
Fig. 1. Geographic locations of Shenzhen and Dongguan
Fig 1 Respiratory support escalation strategies for study patients
Fig 1 Effect of ketamine on the sufentanil enhancement of mechanical hyperalgesia (protocol A). No difference in the measured parameter was observed in.
Fig 1 Perfusion index values at different time intervals in patients with successful and failed blocks. A reference line at PI 3.3 is provided. Horizontal.
Figure 1 Flow chart showing the selection of publications identified in the literature search. From: GnRH antagonist versus long agonist protocols in IVF:
Fig 2 Blood gas analysis during transnasal humidified rapid insufflation ventiror exchange (70 l min−1), and 1 min after oxygenation (12 l min−1)
Fig 1 Coding search and excluded records.
From: Estimating the Location of World Wheat Price Discovery
From: Intention, Interpretation, and Contemporary Visual Art
Fig 2 Regression analysis between transpulmonary pressure and cerebral perfusion pressure during high-frequency oscillatory ventilation (a) and pressure.
Figure 2 Comparison of pregnancy outcomes between true NC-FET and modified NC-FET. Odds ratio (OR) adjusted for clinical pregnancy (OR 0.90, 95% CI 0.73–1.12)
Fig 1 Distribution of GlideScope® videolaryngoscopy and direct laryngoscopy patients from the Paediatric Difficult Intubation Registry. GVL,
FIG. 4. Working lifetime combined risk from fatal heart disease and lung cancer based on Hong Kong exposure to secondhand tobacco smoke and both US and.
Chewing gum for the treatment of postoperative nausea and vomiting: a pilot randomized controlled trial  J.N. Darvall, M Handscombe, K Leslie  British.
Fig. 5 Detailed classifier results for tweets (a) J48, (b) SVM, and (c) NB From: A sentiment analysis system for social media using machine learning techniques:
Fig. 1 Languages used for SA
P. Diemunsch, G.P. Joshi, J.-F. Brichant 
Randomized, double-blind comparison of oral aprepitant alone compared with aprepitant and transdermal scopolamine for prevention of postoperative nausea.
Figure 1. HR (95% CI) of death from dementia associated with weight or BMI in middle age and in old age. From: Adiposity in middle and old age and risk.
Figure 4. Influence of Clerk Ideology on Justice Voting.
Dexamethasone alone vs in combination with transcutaneous electrical acupoint stimulation or tropisetron for prevention of postoperative nausea and vomiting.
R Wengritzky, T Mettho, P.S. Myles, J Burke, A Kakos 
Single-dose aprepitant vs ondansetron for the prevention of postoperative nausea and vomiting: a randomized, double-blind Phase III trial in patients.
Fig. 1. Relative potency ratios of 13 active ingredients used against a fall armyworm population collected in Puerto ... Fig. 1. Relative potency ratios.
(A–B) Images of US ... (A–B) Images of US assessment of both patients who developed peripheral arthritis during vedolizumab treatment undergoing US-guided.
Fig. 1 Bone scintigraphy of the right tibia of the patient at disease onset (A), after 10 years of calcitonin ... Fig. 1 Bone scintigraphy of the right.
Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.
Fig. 1 CT demonstrating aortic wall thickening with renal artery involvement (short arrow). There is also subtle ... Fig. 1 CT demonstrating aortic wall.
bDMARD: biologic DMARD.
Black: diagnosis ... Black: diagnosis from any department; grey: diagnosis at a rheumatology department. Unless provided in the caption above, the following.
Fig. 1 Graphical representation of improving mortality in stroke patients since the inception of a national stroke ... “Graph courtesy of George Dunn,
Fig. 1 MRI aspect of an osteitis of the left acetabulum at baseline (A), 3 months (B), 1 year (C) and 2 years later, ... Fig. 1 MRI aspect of an osteitis.
Fig. 3 Interrelationship between themes describing the experiences of people with shoulder disorders Unless provided in the caption above, the following.
x-axis, post-partum days. Closed ...
Fig. 1. A flowchart of cohort participants screened, enrolled and followed-up between 1 July 2015 and 31 May Fig. 1. A flowchart of cohort participants.
Fig. 1 Subacute cutaneous lupus erythematous at the lower limbs
Fig. 1 Flow chart of included patients for analyses
Rats were treated for 21 days ...
Fig. 1 Flow chart for selection of study subjects
Prevalence and distribution of ...
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Figure 1. Time–kill studies for selected isolates (each line represents the average of duplicate studies). AMP, ... Figure 1. Time–kill studies for selected.
Figure 1. Percentage of Pacific and European children completing all components of B4SC in 2013 and 2015 Figure 1. Percentage of Pacific and European.
Figure 1. Trunk and leg fat over study period. LS, log transformed.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Fig. 1 Kaplan-Meier plot presenting no difference in progression to RA in patients with clinically suspect ... Fig. 1 Kaplan-Meier plot presenting no difference.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Chewing gum for the treatment of postoperative nausea and vomiting: a pilot randomized controlled trial  J.N. Darvall, M Handscombe, K Leslie  British.
Fig. 1 A network representation of top 100 co-occurring terms
Fig. 1 Statistics of the main characters’ dialogues.
Figure 1 Patient selection.
Fig. 1 Query formulation process in CLIR
Figure 1 Grant agencies and charitable foundations supporting Plan S.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Fig. 1 Schematic subcategorization of AAV in three clinically relevant disease categories defined by clinical ... Fig. 1 Schematic subcategorization of.
Figure 1 ABCDE of primary prevention.2
Presentation transcript:

Fig 1 Percentage of patients in the combined modified intent-to-treat population with efficacy endpoints accounting specifically for nausea, by treatment group. VRS, verbal rating scale. *An odds ratio (aprepitant:ondansetron) >1.0, P<0.05 in favour of aprepitant (from Diemunsch and colleagues).<sup>13</sup> From: Neurokinin-1 receptor antagonists in the prevention of postoperative nausea and vomiting Br J Anaesth. 2009;103(1):7-13. doi:10.1093/bja/aep125 Br J Anaesth | © The Author [2009]. Published by Oxford University Press on behalf of The Board of Directors of the British Journal of Anaesthesia. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournal.org 1